Find uplifting stories about heroes, innovations, and solutions
7217 results for "breast cancer treatment"
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Scientists at Oregon Health & Science University created a molecule that shuts down a key enzyme cancer cells need to grow, causing tumors to shrink in mice with triple-negative breast cancer. The breakthrough could lead to new treatments for one of the deadliest forms of breast cancer.
The FDA just approved ENHERTU for early-stage breast cancer treatment, giving patients two new opportunities to stop the disease before it spreads. For the first time in years, doctors can offer new hope to the one in four patients who still face recurrence.
A breast cancer survivor is sharing her healing journey to give others hope. Emily Hester recently appeared on KARK 4 News to talk about her successful treatment for triple-positive breast cancer at CARTI.
Scientists discovered how to beat triple-negative breast cancer at its own game by blocking an enzyme that helps tumors survive treatment. The approach not only damages cancer cells directly but also calls in the immune system for backup.
Scientists developed a simple blood test that reveals which breast cancer treatments will work before patients waste precious time on ineffective options. The breakthrough could help 2 million people diagnosed globally each year get the right treatment faster.
Scientists have discovered an antibody that successfully halted triple-negative breast cancer in laboratory models, offering hope for one of the most difficult cancers to treat. This breakthrough could lead to better treatment options for thousands of women facing this aggressive disease.
Scientists created a peptide that acts like a GPS tracker for metastatic breast cancer cells, successfully targeting and destroying them in mice without harming healthy tissue. The discovery could transform treatment for aggressive cancers that have spread beyond their original location.
The FDA just approved Enhertu for early-stage HER2-positive breast cancer, giving patients a powerful new treatment option before cancer spreads. This marks a major step forward in catching and treating breast cancer when it's most beatable.
More than a million breast cancer patients have benefited from CDK inhibitors, and researchers at Roswell Park are now working to extend these life-saving benefits to other cancer types. New drug combinations and precision medicine approaches could help more patients live longer with fewer side effects.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
Scientists have discovered a molecule that stops triple-negative breast cancer, the most aggressive form that often strikes younger women. The breakthrough treatment shows promise without the toxic side effects that plagued previous cancer therapies.
A breakthrough genomic test could help millions of breast cancer patients avoid unnecessary chemotherapy while maintaining excellent outcomes. The innovation promises to transform treatment decisions for early-stage breast cancer worldwide.
Texas A&M researchers discovered that natural compounds in dark sweet cherries significantly slowed tumor growth and reduced cancer spread in the most aggressive form of breast cancer. The breakthrough offers new hope for treating triple-negative breast cancer, which has limited treatment options.
Scientists discovered a powerful natural molecule from a Chinese plant that attacks the most aggressive form of breast cancer in a completely new way. The compound could open doors for patients who have run out of treatment options.
A groundbreaking treatment for aggressive breast cancer just got FDA approval after helping patients live 14 months longer without their disease progressing. The combination therapy offers new hope for thousands of women battling HER2-positive breast cancer.
Three breakthrough breast cancer medications can now be used in earlier disease stages, giving patients better survival rates with fewer side effects. The drugs previously reserved for late-stage cases are now available for stage two and three patients.
-growing-in-single-files-along-collagen-fibres-(red)_renee-flaherty.jpg%3Fsfvrsn%3Db3bf3bc8_1)
A drug already in trials for blood cancer could transform treatment for lobular breast cancer, a difficult-to-detect form affecting 15% of breast cancer patients. Scientists found the drug slowed tumor growth and spread in mice with minimal side effects.
Women with advanced breast cancer now have a powerful new treatment option that postpones the need for chemotherapy. The combination of giredestrant and Afinitor offers hope for patients seeking gentler alternatives to traditional cancer treatment.
The UAE just became the first country in the world to approve a groundbreaking breast cancer treatment for patients with a specific gene mutation. This milestone reflects the nation's commitment to fast-tracking life-saving innovations for patients who need them most.
Showing 20 of 7217